Feature Article

Atopic dermatitis – an update on management in general practice

Feature Article

Atopic dermatitis – an update on management in general practice

ALEXIS ARASU, GAYLE ROSS

Figures

© cunaplus_M.faba/ istockphoto.com
© cunaplus_M.faba/ istockphoto.com

Abstract

Atopic dermatitis is a common, chronic and often debilitating inflammatory skin disorder with a large burden of its diagnosis and management falling within primary care. New advancements and updates to management are significantly improving the outcomes for patients with this condition.
Correction
A correction for this article was published in the May 2022 issue of Medicine Today. The online version and the full text PDF of this article (see link above) have been corrected.

Key Points

  • Atopic dermatitis is a common condition and is largely managed in the primary care setting.
  • Understanding and quantifying the impact of the condition on quality of life is important when tailoring therapy for patients.
  • First-line therapy involves robust education around general measures and commencement of appropriate topical corticosteroid therapy.
  • Should patients fail to respond to optimised general measures and topical corticosteroids after one month, they should be referred to a dermatologist.
  • Dupilumab and upadacitinib are new advanced therapies that have profound benefits for patients with severe atopic dermatitis and have recently been added to the Pharmaceutical Benefits Scheme.